Fig. 2From: Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)a to c. MSDS 3D TREAT-MS module: start pageBack to article page